论文部分内容阅读
为探讨血清唾液酸(SA)在原发性肝癌中的变化规律及临床意义,我们检测40例原发性肝癌及其他肝病的SA水平,并与甲种胎儿球蛋白(AFP)、肝癌试验(HCT)相比较,分析其临床意义。现报告如下。 1 材料与方法:选择原发性肝癌40例、肝硬化25例、慢性活动性肝炎(慢活肝)70例、慢性迁延性肝炎(慢迁肝)15例、急性肝炎(急肝)恢复期20例和100名健康人血清,检测SA(比色法,上海海军医学研究所试剂盒)、HCT(定性法,长春兽医大学试剂盒)、AFP(放免法,正常值≤25ng/ml)及肝功能试验等。
To investigate the changes and clinical significance of serum sialic acid (SA) in primary hepatocellular carcinoma (HCC), we detected SA levels in 40 patients with primary hepatocarcinoma and other liver diseases and compared them with AFP, HCT) compared to analyze its clinical significance. The report is as follows. MATERIAL AND METHODS: Forty patients with primary liver cancer, 25 with cirrhosis, 70 with chronic active hepatitis (chronic active liver), 15 with chronic persistent hepatitis (slow-moving liver), 15 with acute hepatitis (acute liver) 20 cases and 100 healthy human serum were detected by SA (colorimetric method, Shanghai Navy Medical Institute kit), HCT (qualitative method, Changchun Veterinary University kit), AFP (radioimmunity, normal ≤ 25ng / ml) and Liver function tests.